Carlos Abud‐Mendoza

Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis

Joel M. Kremer, Harry K. Genant, Larry W. Moreland et al. · Annals of Internal Medicine · 2006 · 710 citations

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier et al. · The Lancet · 2008 · 543 citations

Rheumatoid Disorder, Rheumatology, Juvenile Idiopathic Arthritis +8

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

William Stohl, Falk Hiepe, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 408 citations · Full text

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 345 citations · Full text